MGTX

MeiraGTx Holdings plc

5.80 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

MeiraGTx Holdings plc stock is down -14.07% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 February’s closed higher than January.

About MeiraGTx Holdings plc

MeiraGTx Holdings plc focuses on developing treatments for patients with serious diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop a gene therapy treatment using the company's proprietary riboswitch technology.